Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment

Dole, 1965, A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride, JAMA., 193, 646, 10.1001/jama.1965.03090080008002

Nichols, 1971, Outpatient induction to methadone maintenance treatment for heroin addiction, Arch Intern Med., 127, 903, 10.1001/archinte.1971.00310170111015

Leavitt, Methadone dosing & safety in the treatment of opiate addiction, Addict Treat Forum.

Nicholls, 2010, Opioid dependence treatment and guidelines, J Manag Care Pharm., 16, S14, 10.18553/jmcp.2010.16.S1-B.14

Bell, 2000, A risk-benefit analysis of methadone maintenance treatment, Drug Saf., 22, 179, 10.2165/00002018-200022030-00002

Langrod, 1981, Methadone treatment and physical complaints: A clinical analysis, Int J Addict., 16, 947, 10.3109/10826088109038903

Dyer, 1997, Patterns of symptom complaints in methadone maintenance patients, Addiction., 92, 1445, 10.1111/j.1360-0443.1997.tb02866.x

Elkader, 2009, Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment, Drug Alcohol Depend., 105, 209, 10.1016/j.drugalcdep.2009.07.003

Belding, 1996, Coping strategies and continued drug use among methadone maintenance patients, Addict Behav., 21, 389, 10.1016/0306-4603(95)00069-0

Barta, 2009, Craving and self-efficacy in the first five weeks of methadone maintenance therapy: A daily process study, J Stud Alcohol Drugs., 70, 735, 10.15288/jsad.2009.70.735

Gottheil, 1993, Diminished illicit drug use as a consequence of long-term methadone maintenance, J Addict Dis., 12, 45, 10.1300/J069v12n04_04

Weinstein, 1993, Long-term methadone maintenance treatment: Some clinical examples, J Subst Abuse Treat., 10, 277, 10.1016/0740-5472(93)90075-D

DeMaria, 2000, The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment, Am J Addict., 9, 145, 10.1080/10550490050173217

Nurco, 1988, Nonnarcotic drug use over an addiction career-A study of heroin addicts in Baltimore and New York City, Compr Psychiatry., 29, 450, 10.1016/0010-440X(88)90060-0

Nirenberg, 1996, Cannabis versus other illicit drug use among methadone maintenance patients, Psychol Addict Behav., 10, 222, 10.1037/0893-164X.10.4.222

Church, 2001, Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence, Am J Drug Alcohol Abuse., 27, 441, 10.1081/ADA-100104511

San, 1993, Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: Results from cross-sectional studies in 1988 and 1990, Addiction., 88, 1341, 10.1111/j.1360-0443.1993.tb02020.x

Hermann, 2005, Low efficacy of non-opioid drugs in opioid withdrawal symptoms, Addict Biol., 10, 165, 10.1080/13556210500123514

Degenhardt, 2001, The relationship between cannabis use and other substance use in the general population, Drug Alcohol Depend., 64, 319, 10.1016/S0376-8716(01)00130-2

Frauger, 2008, Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004, Therapie., 63, 119, 10.2515/therapie:2008037

Maremmani, 2010, Differential substance abuse patterns distribute according to gender in heroin addicts, J Psychoactive Drugs., 42, 89, 10.1080/02791072.2010.10399789

Saxon, 1990, Marijuana use by methadone maintenance patients, NIDA Res Monogr., 105, 306

Ellner, 1977, Marijuana use by heroin abusers as a factor in program retention, J Consult Clin Psychol., 45, 709, 10.1037/0022-006X.45.4.709

DuPont, 1989, Marijuana and benzodiazepines in patients receiving methadone treatment, JAMA., 261, 3409, 10.1001/jama.1989.03420230061018

Budney, 1998, Marijuana use and treatment outcome among opioid-dependent patients, Addiction., 93, 493, 10.1046/j.1360-0443.1998.9344935.x

Nixon, 2003, Cannabis use and treatment outcome in methadone maintenance, Addiction., 98, 1321, 10.1046/j.1360-0443.2003.00532.x

Epstein, 2003, Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against, Addiction., 98, 269, 10.1046/j.1360-0443.2003.00310.x

Raby, 2009, Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence, Am J Addict., 18, 301, 10.1080/10550490902927785

De Vries, 2003, Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats, Psychopharmacology (Berl)., 168, 164, 10.1007/s00213-003-1422-1

Lichtman, 2001, Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice, J Pharmacol Exp Ther., 298, 1007

Navarro, 2001, Functional interaction between opioid and cannabinoid receptors in drug self-administration, J Neurosci., 21, 5344, 10.1523/JNEUROSCI.21-14-05344.2001

Cichewicz, 2004, Synergistic interactions between cannabinoid and opioid analgesics, Life Sci., 74, 1317, 10.1016/j.lfs.2003.09.038

Manzanares, 1999, Pharmacological and biochemical interactions between opioids and cannabinoids, Trends Pharmacol Sci., 20, 287, 10.1016/S0165-6147(99)01339-5

Valverde, 2001, Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: Reduction in morphine withdrawal syndrome without change in rewarding effect, Eur J Neurosci., 13, 1816, 10.1046/j.0953-816x.2001.01558.x

Fattore, 2007, Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55, 212-2, Eur J Neurosci., 25, 2191, 10.1111/j.1460-9568.2007.05470.x

Fattore, 2005, Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats, Neuropharmacology., 48, 1097, 10.1016/j.neuropharm.2005.01.022

Tham, 2005, Synergistic and additive interactions of the cannabinoid agonist CP55, 940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice, Br J Pharmacol., 144, 875, 10.1038/sj.bjp.0706045

Cox, 2007, Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat, Eur J Pharmacol., 567, 125, 10.1016/j.ejphar.2007.04.010

Roberts, 2006, Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine, Eur J Pharmacol., 530, 54, 10.1016/j.ejphar.2005.11.036

Cichewicz, 2003, Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration, J Pharmacol Exp Ther., 304, 1010, 10.1124/jpet.102.045575

Wesson, 2003, The clinical opiate withdrawal scale (COWS), J Psychoactive Drugs., 35, 253, 10.1080/02791072.2003.10400007

Parolaro, 2010, Cellular mechanisms underlying the interaction between cannabinoid and opioid system, Curr Drug Targets., 11, 393, 10.2174/138945010790980367

Vigano, 2005, Molecular and cellular basis of cannabinoid and opioid interactions, Pharmacol Biochem Behav., 81, 360, 10.1016/j.pbb.2005.01.021

Saxon, 1993, Urine screening for marijuana among methadone-maintained patients, Am J Addict., 2, 207, 10.1111/j.1521-0391.1993.tb00421.x

Weizman, 2004, Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: A 1-year prospective study in an Israeli clinic, Aust N Z J Psychiatry., 38, 42, 10.1046/j.1440-1614.2003.01296.x

Aharonovich, 2005, Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: A prospective study, Am J Psychiatry., 162, 1507, 10.1176/appi.ajp.162.8.1507

Wasserman, 1998, Factors associated with lapses to heroin use during methadone maintenance, Drug Alcohol Depend., 52, 183, 10.1016/S0376-8716(98)00092-1

Nava, 2007, Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts, Prog Neuropsychopharmacol Biol Psychiatry., 31, 1089, 10.1016/j.pnpbp.2007.03.013

Musshoff, 2010, Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs, Int J Legal Med., 124, 499, 10.1007/s00414-009-0361-8

Hallinan, 2009, Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: A transnational study, Eur J Clin Pharmacol., 65, 1113, 10.1007/s00228-009-0706-8

Frederickson, 1976, Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: Their antagonism by l-(−)-delta9-tetrahydrocannabinol, J Pharmacol Exp Ther., 199, 375

Yamaguchi, 2001, Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice, Brain Res., 909, 121, 10.1016/S0006-8993(01)02655-5

Cichewicz, 2003, Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol, J Pharmacol Exp Ther., 305, 812, 10.1124/jpet.102.046870

Vela, 1995, Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine, Neuropharmacology., 34, 665, 10.1016/0028-3908(95)00032-2